Moreover, we demonstrate that ABHD11 inhibition allows 2-OG metabolism to be modulated in multiple cells and in a reversible manner, with potential broad implications for altering cell fate-decisions and manipulating 2-OG abundance in tumours. This evidence concerns the gene ABHD11 and neoplasm.